Clinical

Dataset Information

0

Pemetrexed Alone as Salvage Treatment in Metastatic Colorectal Cancer Patients Who Were Failed After Standard Chemotherapy: A Phase II Single Arm Prospective Study


ABSTRACT: Pemetrexed is an anticancer agent that exerts its action by disrupting crucial folate-dependent metabolic processes essential for cell replication. In vitro studies have shown that pemetrexed behaves as a multitargeted antifolate by inhibiting thymidylate synthase (TS), dihydrofolate reductase (DHFR), and glycinamide ribonucleotide formyltransferase (GARFT), which are key folate-dependent enzymes for the de novo biosynthesis of thymidine and purine nucleotides.Pemetrexed is used as a standard therapeutic agent for lung cancer, pleural mesothelioma, peritoneal mesothelioma.In addition to these effective anti-cancer effect, Pemetrexed is not severe side effects of the medicine. Pemetrexed has been research in colon cancer. Zhang, etc., demonstrated the anti-cancer effect of Pemetrexed in human colon cancer Cells. Although sometimes made also two or more clinical studies, Pemetrexed was reported 15-17% of the treatment response rate in these two studies.

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2201098 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2018-06-06 | PXD007056 | Pride
| 2211418 | ecrin-mdr-crc
2021-10-28 | GSE159380 | GEO
2021-10-28 | GSE159349 | GEO
2010-03-03 | E-GEOD-14645 | biostudies-arrayexpress
2005-01-01 | MODEL6655501972 | BioModels
| PRJNA682394 | ENA
2013-10-28 | E-GEOD-50692 | biostudies-arrayexpress
2013-10-28 | GSE50692 | GEO
2009-10-01 | GSE14645 | GEO